Glioblastoma remains one of the most lethal primary brain tumors, with limited durable benefit from current standard-of-care approaches. In parallel, ...
Tevogen Bio Holdings Inc. has announced its new artificial intelligence initiative, Tevogen.AI™, aimed at enhancing its ExacTcell™ technology for improved target identification and preclinical ...
Ultimately, Dr. Minn notes, success in immuno-oncology will be measured in multiple ways: Scientifically, by the depth of ...
Cytokines are small, secreted proteins that transmit messages between cells and members of this superfamily include chemokines, growth factors, interleukins, interferons, colony stimulating factors, ...
Researchers have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body. In a new study published today in Nature ...
After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – ...
REDWOOD CITY, Calif. & SHENZHEN, China--(BUSINESS WIRE)--LTZ Therapeutics, an immunotherapy-focused biotech company, today announced the completion of the company’s Series A financing of over $20 ...
Members include Nobel laureate James P. Allison, Padmanee Sharma, Taha Merghoub, and Kingston Mills, who are all globally renowned experts in ...
Until recently, allergy treatment was largely based on average treatment schemes. A patient with pollen allergy would receive ...